EU Approvals Beckon For Inrebic & Novel Adalimumab Biosimilar

TETEC Withdraws EU Filing for ATMP For Cartilage Defects

 
• By Neena Brizmohun
ApproveOnKeyboard_1200x675
EU marketing approvals are on the cards for new drugs • Source: Shutterstock

More from Europe

More from Geography